Cohance Lifesciences informs about disclosure
Date: 12-08-2026Cohance Lifesciences has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for DSP Trustee.
The above information is a part of company’s filings submitted to BSE.